Hemostemix's market cap is currently C$19.08M. The company's EPS TTM is C$-0.002; its P/E ratio is ―; Hemostemix is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
